Showing results (131-140 of 492) with videos related to
Sort By:
Pageof 50
Clinical Lymphoma & Myeloma|April 14, 2009
Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemiaMary L McMaster, Sigurdur Y Kristinsson, Ingemar Turesson, et al.British Journal of Haematology|March 7, 2012
Increased incidence of chronic lymphocytic leukaemia and lymphomas in patients with Merkel cell carcinoma - a population based study of 335 cases with neuroendocrine skin tumourTamar Tadmor, Irena Liphshitz, Ariel Aviv, et al.Expert Review of Molecular Diagnostics|July 13, 2011
Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical managementSigurdur Y Kristinsson, Alex R Minter, Neha Korde, et al.Haematologica|April 19, 2012
Thrombosis is associated with inferior survival in multiple myelomaSigurdur Y Kristinsson, Ruth M Pfeiffer, Magnus Björkholm, et al.Leukemia & Lymphoma|June 5, 2014
The effects of cardiovascular disease on the clinical outcome of elderly patients with diffuse large B-cell lymphomaHuei-Ting Tsai, Ruth M Pfeiffer, Joan Warren, et al.Blood Cancer Journal|February 1, 2020
Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaVenkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.Blood Cancer Journal|December 13, 2019
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaVenkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.JAMA Oncology|December 13, 2019
Moving From Cancer Burden to Cancer Genomics for Smoldering Myeloma: A ReviewFrancesco Maura, Niccolò Bolli, Even H Rustad, et al.Future Oncology (London, England)|August 10, 2019
Humanistic and economic impact of subcutaneous versus intravenous administration of oncology biologicsKenneth C Anderson, Ola Landgren, Rebecca C Arend, et al.European Journal of Haematology|April 21, 2018
Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survivalIngemar Turesson, Magnus Bjorkholm, Cecilie Hveding Blimark, et al.Pageof 50